MADRIGAL PHARMACEUTICALS INC's ticker is MDGL and the CUSIP is 558868105. A total of 134 filers reported holding MADRIGAL PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.56 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $249,286 | -65.9% | 1,029 | -83.6% | 0.00% | -66.7% |
| Q1 2021 | $732,000 | -42.5% | 6,260 | -45.4% | 0.00% | -40.0% |
| Q4 2020 | $1,274,000 | -5.3% | 11,462 | +1.1% | 0.01% | -16.7% |
| Q3 2020 | $1,346,000 | -8.6% | 11,337 | -12.8% | 0.01% | -14.3% |
| Q2 2020 | $1,472,000 | +73.0% | 12,997 | +2.0% | 0.01% | +40.0% |
| Q1 2020 | $851,000 | +295.8% | 12,742 | +520.7% | 0.01% | +400.0% |
| Q2 2019 | $215,000 | – | 2,053 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HealthCor Management, L.P. | 902,601 | $100,342,000 | 3.87% |
| L1 Capital Pty Ltd | 113,464 | $12,608,000 | 2.35% |
| Avoro Capital Advisors LLC | 1,225,000 | $136,183,000 | 2.34% |
| Tao Capital Management LP | 51,396 | $5,714,000 | 1.40% |
| ARMISTICE CAPITAL, LLC | 316,000 | $35,130,000 | 1.20% |
| ACUTA CAPITAL PARTNERS, LLC | 32,500 | $3,613,000 | 0.98% |
| Capital Impact Advisors, LLC | 24,351 | $2,707,000 | 0.66% |
| Baker Brothers Advisors | 1,499,213 | $166,668,000 | 0.63% |
| Rock Springs Capital Management LP | 256,768 | $28,545,000 | 0.60% |
| SHIKIAR ASSET MANAGEMENT INC | 12,000 | $1,334,000 | 0.48% |